New Sepsis Drug Shows Promise in 180-Patient Trial

A breakthrough drug candidate successfully reduced sepsis symptoms in a 180-patient trial, offering hope for a condition that kills millions worldwide. Researchers at Griffith University could bring the first specific anti-sepsis therapy to market within years.